CRL
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Latest Form 4:Sale$10.1MbyFOSTER JAMES C (Director) · filed Aug 27, 2026
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) has 55 SEC Form 4 filings (113 transaction rows) in the rolling window, disclosed by 7 distinct insiders. Most recent filing: Aug 27, 2026.
The most active filer is Director FOSTER JAMES C with 3 filings. Insiders have net sold $42.6M over the trailing 6 months.
- Industry:Medical - Diagnostics & Research
- CEO:James C. Foster
- Employees:18,700
- HQ:Wilmington, MA, US
- IPO:2000-06-23
Insider Buying
$4K
reported purchases (SEC code P)
Insider Selling
$42.7M
reported sales (SEC code S)
Unique Insiders
7
in the rolling window
Market Cap
$14.2B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Director | Sale | 33,561 | $10.1M | Aug 27 | SEC ↗ | |
| CEVP, Disc & Safety Assessment | Sale | 2,039 | $600K | Aug 20 | SEC ↗ | |
Andrews Nancy CFirst filing | Director | Sale | 573 | $163K | Aug 20 | SEC ↗ |
| CEVP, Disc & Safety Assessment | Sale | 3,714 | $1.0M | Aug 13 | SEC ↗ | |
Girshick BirgitFirst filing | Chief Executive Officer | Sale | 6,500 | $1.8M | Aug 13 | SEC ↗ |
| Director | Sale | 28,733 | $7.9M | Aug 11 | SEC ↗ | |
Knell Michael GunnarFirst filing | SVP, Finance and CAO | Sale | 6,645 | $1.7M | Aug 10 | SEC ↗ |
Creamer Victoria LFirst filing | EVP & Chief People Officer | Sale | 4,179 | $1.1M | Aug 10 | SEC ↗ |
Parisotto Shannon MFirst filing | CEVP, Disc & Safety Assessment | Sale | 5,046 | $1.3M | Aug 6 | SEC ↗ |
FOSTER JAMES CFirst filing | Director | Sale | 75,000 | $16.9M | Jul 1 | SEC ↗ |
| EVP, Corp Strategy & Develop | Purchase | 25 | $4K | Mar 4 | SEC ↗ | |
LaPlume Joseph WFirst filing | EVP, Corp Strategy & Develop | Sale | 400 | $65K | Jan 20 | SEC ↗ |
Related companies
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. is in the Services sector.